SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Thermo Fisher Scientific recognizes significance of FDA approval of first CAR-T cell immunotherapy for multiple myeloma with donation to Leukemia and Lymphoma Society

Thermo Fisher Scientific
29 Apr 2021
Edward Carter
Publishing / Media

Industry news

Thermo Fisher Scientific has made a donation to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval of the first CAR-T cell immunotherapy for multiple myeloma developed by Bristol Myers Squibb and bluebird bio.

Abecma® (idecabtagene vicleucel; ide-cel) is a chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of certain adult patients with relapsed or refractory multiple myeloma, a blood cancer formed by malignant plasma cells and typically originating in the bone marrow.

The lentiviral vector used to engineer patients’ T cells was developed by bluebird bio and is manufactured at Thermo Fisher’s viral vector manufacturing site in Cambridge, Mass., which received a commercial license for viral vector manufacturing.

“We congratulate Bristol Myers Squibb and bluebird bio on this important achievement and bringing the first B-cell maturation antigen (BCMA)-directed CAR-T cell therapy for patients with multiple myeloma experiencing the devastating effects of this disease,” said Mike Shafer, senior vice president, pharma services, Thermo Fisher Scientific. “We are proud to be a partner in bringing this novel treatment to patients.”

The site in Cambridge is part of Thermo Fisher’s growing global network of cell and gene therapy facilities, which include fully integrated development and manufacturing capabilities: viral vector services in Cambridge, Lexington and Plainville, Mass.; Alachua, Fla.; Gosselies and Seneffe, Belgium; GMP plasmids manufacturing in Carlsbad, Calif. and Watertown, Mass.; cell therapy manufacturing in Princeton, NJ; cryogenic and cold chain supply chain services in Rockville and Frederick, MD; Franklin, Mass.; Vacaville, Calif.; Bishop’s Stortford and Stevenage, UK; Weil am Rhein, Germany; and Tokyo, Japan.

Do you want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Thermo Fisher ScientificCompany website

Tags

Cell Lines Stem Cells and Primary CellsPrimary cell cultures, established cell lines and stem cells are vital for <i>in vitro</i> and <i>ex vivo</i> experimentation. High-quality cells, optimized for your applications, alongside optimized cell substrates, growth medium and supplements, are critical for experimental success. Explore a range of cells suitable for your applications, including isogenic cell lines, competent cells, induced pluripotent stem cell (iPSC)-derived cell lines, fungal/bacterial/mammalian cell lines, stem cells and cancer cell lines. Find the best cells for your research in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.LeukemiaImmunotherapyImmunotherapy is a treatment approach that utilizes the body�s immune system to fight diseases, especially cancer. It includes therapies such as monoclonal antibodies, checkpoint inhibitors, and CAR-T cell therapy. Immunotherapy is a rapidly growing area of research in oncology and autoimmune diseases. Browse our peer-reviewed product directory to find the best immunotherapy tools, compare products, check reviews, and get pricing directly from manufacturers.Cancer ResearchAlthough cancer is often referred to as a single condition, it actually consists of more than 100 different diseases. Microscopy, mass spectrometry, high throughput sequencing and flow cytometry are some of the most common techniques employed in cancer research labs.

Related articles

Thermo Fisher Scientific recognizes significance of FDA approval of first CAR-T cell immunotherapy for multiple myeloma with donation to Leukemia and Lymphoma Society